(VIANEWS) – TravelCenters of America LLC (TA), Expedia Group (EXPE), Lakeland Financial Corporation (LKFN) are the highest sales growth and return on equity stocks on this list.

Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. TravelCenters of America LLC (TA)

44% sales growth and 11.83% return on equity

TravelCenters of America Inc. manages travel centers and truck service facilities in both the United States of America and Canada. It offers a variety of products and services including gasoline and diesel, along with non-fuel products and service such as truck repairs and maintenance, diesel exhaust fluids and full service restaurants and quick service restaurants. The company’s quick and full service restaurants operate under Country Pride, IHOP and Black Bear Diner brands. General merchandise includes electronics, oil, additives and hardware, tools and clothing; convenience products include cold drinks, candy and snacks; health and beauty products and meal solutions; fresh food and pre-packaged meals; cold fountain drinks; gifts; souvenirs and gift ideas; and cold beverages. It also operates parking spaces under the Reserve-It name. The company had 276 TravelCenters of America and TA brands in operation as of December 31, 2021. It also operated three truck services facilities under the TA Truck Service name and one restaurant. The company serves the trucking industry, its drivers and independent truck drivers as well as local and highway motorists. TravelCenters of America Inc. is an Ohio-based company that was established in Westlake in 1972.

Earnings Per Share

As for profitability, TravelCenters of America LLC has a trailing twelve months EPS of $-0.06.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 11.83%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 50.2%, now sitting on 8.1B for the twelve trailing months.

2. Expedia Group (EXPE)

18.3% sales growth and 13% return on equity

Expedia Group, Inc. is an international online travel agency that operates in the United States. It operates in three segments: Retail, B2B and Trivago. Brand Expedia is an online travel agency that offers full-service, localized services. Hotels.com and Vrbo are online platforms for finding and booking alternative lodging. Hotwire provides travel booking services. CarRentals.com allows you to book car rentals online. Classic Vacations, an expert in luxury travel, and Expedia Cruise gives advice on booking cruises. Expedia Partner Solutions is a brand for business that offers travel and non-travel services. This includes travel agencies, corporate travel management and online retail. Egencia provides corporate travel management. Trivago is a website that allows you to refer people to travel agencies and service providers via hotel websites. Expedia Group Media Solutions completes the brand portfolio. The company also offers online travel services via its Wotif.com.au and travel.com.au brands, loyalty programs, hotel accommodations, and other accommodations. The company serves corporate and leisure travelers. The former name of the company was Expedia, Inc., but it changed its name in March 2018 to Expedia Group, Inc. Expedia Group, Inc. is located in Seattle, Washington.

Earnings Per Share

As for profitability, Expedia Group has a trailing twelve months EPS of $-19.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 13%.

3. Lakeland Financial Corporation (LKFN)

18.2% sales growth and 15.77% return on equity

Lakeland Financial Corporation is the bank holding organization for Lake City Bank. It offers a variety of banking products and services. It accepts different deposit types, including interest bearing checking and savings. The company offers loans for commercial, industrial, multi-family residential, commercial real property, agricultural, and consumer 1-4 mortgages. It also provides retail and merchant credit cards services; corporate wealth advisory and trust services; retail brokerage, which includes various investment and financial products such as annuities, life insurance, and online banking. The company serves the following industries: commercial real estate; manufacturing, agriculture, construction; retail, wholesale finance, insurance, food and accommodation services and health care. The company had 50 locations in 15 counties as of December 31, 2020. There were 44 offices located in northern Indiana, and six in central Indiana. Lakeland Financial Corporation was established in Warsaw in Indiana in 1872.

Earnings Per Share

As for profitability, Lakeland Financial Corporation has a trailing twelve months EPS of $3.81.

PE Ratio

Lakeland Financial Corporation has a trailing twelve months price to earnings ratio of 20.32. Meaning,
the purchaser of the share is investing $20.32 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 15.77%.

Volume

Today’s last reported volume for Lakeland Financial Corporation is 333743 which is 177.35% above its average volume of 120330.

Sales Growth

Lakeland Financial Corporation’s sales growth is 11.1% for the ongoing quarter and 18.2% for the next.

4. Corcept Therapeutics Incorporated (CORT)

13.4% sales growth and 23.36% return on equity

Corcept Therapeutics Incorporated develops and markets drugs to treat severe metabolic and oncologic disorders. Korlym (mifepristone), a once daily oral medication, is offered to treat hyperglycemia secondary hypercortisolism among adult Cushing’s patients. This treatment can be used for type 2 diabetes or other conditions that result in the need for insulin. The company is currently developing relacorilant for Cushing’s patients; and nabpaclitaxel combined with relacorilant. Phase II clinical trials have been completed to treat serous ovarian cancers. Phase III clinical trials are underway to treat solid tumors. The company is also developing selective cortisol modulator combined with Xtandi that is in open label dose finding trial to treat patients with metastatic castration-resistant prostate cancer; selective cortisol modulator for the treatment of antipsychotic-induced weight gain; and FKBP5 gene expression assays. Corcept Therapeutics Incorporated is located in Menlo Park in California. It was established in 1998.

Earnings Per Share

As for profitability, Corcept Therapeutics Incorporated has a trailing twelve months EPS of $0.93.

PE Ratio

Corcept Therapeutics Incorporated has a trailing twelve months price to earnings ratio of 27.41. Meaning,
the purchaser of the share is investing $27.41 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 23.36%.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Corcept Therapeutics Incorporated’s EBITDA is 6.06.

Yearly Top and Bottom Value

Corcept Therapeutics Incorporated’s stock is valued at $25.49 at 01:22 EST, way under its 52-week high of $29.93 and way above its 52-week low of $15.83.

Revenue Growth

Year-on-year quarterly revenue growth grew by 12.9%, now sitting on 392.03M for the twelve trailing months.

Sales Growth

Corcept Therapeutics Incorporated’s sales growth for the next quarter is 13.4%.

LEAVE A REPLY

Please enter your comment!
Please enter your name here